Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

2.1K
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
2.1K
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

2.1K
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
2.1K
Karyotyping01:17

Karyotyping

70.0K
Overview
70.0K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

400
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
400
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

611
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
611
Imaging Studies II: Ultrasonography01:24

Imaging Studies II: Ultrasonography

720
IntroductionUltrasonography, or renal ultrasound, is a noninvasive medical imaging technique that uses high-frequency sound waves to visualize the kidneys, ureters, bladder, and surrounding tissues.Indications for Urinary System UltrasonographyUrinary system ultrasonography is indicated in various clinical scenarios, such as:Kidney Stones (Urolithiasis): To detect and monitor the size and presence of kidney or urinary tract stones.Hydronephrosis: To assess the dilation of the renal pelvis and...
720

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plain balloon angioplasty +/- bare metal stenting versus drug-coated balloon angioplasty +/- bare metal stenting versus primary drug-eluting stenting in patients with chronic limb-threatening ischaemia: BASIL-3, an open-label, three-arm, randomised, multi-centre, phase 3 trial.

Health technology assessment (Winchester, England)·2026
Same author

Sample Size Guidance and Justification for Studies of Biological Variability.

The journal of applied laboratory medicine·2026
Same author

Recommendations for Research and Clinical Implementation of Ambulatory Assessment, Mood Monitoring, Digital Phenotyping, and Remote Measurement Technology in Mood Disorders: Synthesis of Systematic Review Findings.

JMIR mental health·2026
Same author

Developing a job retention vocational rehabilitation intervention for people with long covid: a person-based approach.

BMJ open·2026
Same author

Preparation for online psychological therapy for depression in people living with and beyond cancer in East Midlands NHS primary and secondary care services in England: protocol for the PROSPER randomised controlled trial.

BMJ open·2026
Same author

QUADAS-3 Explanation and Elaboration: Guidance for Quality Assessment of Diagnostic Test Accuracy Studies.

Annals of internal medicine·2026
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

1.1K

Urine tests for Down's syndrome screening.

S Kate Alldred1, Boliang Guo, Yemisi Takwoingi

  • 1Department of Women's and Children's Health, The University of Liverpool, First Floor, Liverpool Women's NHS Foundation Trust, Crown Street, Liverpool, UK, L8 7SS.

The Cochrane Database of Systematic Reviews
|December 15, 2015
PubMed
Summary
This summary is machine-generated.

Second trimester urine markers, including beta-core fragment and estriol with maternal age, show improved accuracy for Down

More Related Videos

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
06:55

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Published on: May 8, 2021

6.4K
Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

14.4K

Related Experiment Videos

Last Updated: Mar 28, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

1.1K
Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
06:55

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Published on: May 8, 2021

6.4K
Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

14.4K

Area of Science:

  • Genetics and Prenatal Diagnostics
  • Biochemical Markers in Pregnancy
  • Maternal Serum Screening

Background:

  • Down's syndrome, caused by trisomy 21, is the most common cause of congenital intellectual disability, associated with various health issues.
  • Pregnancy risk for Down's syndrome increases with maternal age; non-invasive screening aids in decision-making for definitive testing.
  • Informed consent is crucial, requiring parents to understand screening risks, benefits, and implications of false positives/negatives.

Purpose of the Study:

  • To assess and compare the diagnostic accuracy of first and second-trimester maternal urine markers for Down's syndrome detection.
  • To evaluate the effectiveness of various marker combinations and the influence of maternal age on screening performance.

Main Methods:

  • A comprehensive literature search identified 19 studies (18,013 pregnancies) evaluating maternal urine tests up to 24 weeks gestation.
  • Meta-analysis using hierarchical summary ROC curves assessed test performance, including sensitivity and false positive rates.
  • Quality assessment (QUADAS criteria) and subgroup analyses (maternal age impact) were performed.

Main Results:

  • Nineteen studies evaluated 24 test combinations using markers like alpha-fetoprotein, hCG, estriol, and beta-core fragment, with or without maternal age.
  • The double marker test (second-trimester beta-core fragment and estriol with maternal age) showed significantly better diagnostic accuracy than single marker tests.
  • Specifically, at a 5% false positive rate, this double marker test achieved 73% sensitivity, compared to 56% for beta-core fragment and maternal age alone.

Conclusions:

  • Second-trimester urine marker tests combining beta-core fragment and estriol with maternal age demonstrate improved sensitivity for Down's syndrome detection.
  • However, the evidence base is limited, with few studies directly comparing these combinations.
  • Further research is needed to support the routine clinical use of urine testing for Down's syndrome screening, especially when alternative methods are available.